Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Biochim Biophys Acta ; 1794(10): 1517-29, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19596087

ABSTRACT

In mice, amyloidogenic type C apolipoprotein A-II (apoA-II) forms amyloid fibrils in age-associated amyloidosis. To understand the mechanism of amyloid fibril formation by apoA-II, we examined the polymerization of synthetic partial peptides of apoA-II in vitro. None of the partial apoA-II peptides polymerized into amyloid fibrils when tested as a single species mixture. We found a unique mechanism in which N- and C-terminal peptides associated into amyloid fibrils in a 1:1 ratio at pH 2.5. The 11-residue amino acid sequence (6-16), which is a common sequence of type B apoA-II and type C apoA-II proteins in amyloidosis-resistant mice and amyloidosis-susceptible mice, respectively, was critical for polymerization into amyloid fibrils. The 18-residue-long amino acid sequence (48-65) is also necessary for nucleation, but not for the extension phase. These findings suggest that there may be different mechanisms underlying the nucleation and extension phases of apoA-II amyloid fibril formation. We also found that amino acid substitutions between type B apoA-II (Pro5, Val38) and type C apoA-II (Gln5, Ala38) did not affect either phase. The strategy of using synthetic partial peptides of amyloidogenic proteins in vitro is a useful system for understanding amyloid fibril formation and for the development of novel therapies.


Subject(s)
Amyloid/biosynthesis , Amyloid/chemistry , Apolipoprotein A-II/chemistry , Apolipoprotein A-II/metabolism , Amino Acid Sequence , Amino Acid Substitution , Amyloid/genetics , Amyloid/ultrastructure , Amyloidosis/etiology , Amyloidosis/metabolism , Animals , Apolipoprotein A-II/genetics , Circular Dichroism , Hydrogen-Ion Concentration , In Vitro Techniques , Mice , Microscopy, Electron, Transmission , Models, Biological , Molecular Sequence Data , Peptide Fragments/chemistry , Peptide Fragments/genetics , Peptide Fragments/metabolism
2.
Biochem J ; 416(2): 307-15, 2008 Dec 01.
Article in English | MEDLINE | ID: mdl-18637792

ABSTRACT

Abeta2M (beta(2)-microglobulin-related) amyloidosis is a frequent and serious complication in patients on long-term dialysis. Partial unfolding of beta2-m (beta(2)-microglobulin) may be essential to its assembly into Abeta2M amyloid fibrils in vivo. Although SDS around the critical micelle concentration induces partial unfolding of beta2-m to an alpha-helix-containing aggregation-prone amyloidogenic conformer and subsequent amyloid fibril formation in vitro, the biological molecules with similar activity under near-physiological conditions are still unknown. The effect of various NEFAs (non-esterified fatty acids), which are representative anionic amphipathic compounds in the circulation, on the growth of Abeta2M amyloid fibrils at a neutral pH was examined using fluorescence spectroscopy with thioflavin T, CD spectroscopy, and electron microscopy. Physiologically relevant concentrations of laurate, myristate, oleate, linoleate, and mixtures of palmitate, stearate, oleate and linoleate, induced the growth of fibrils at a neutral pH by partially unfolding the compact structure of beta2-m to an aggregation-prone amyloidogenic conformer. In the presence of human serum albumin, these NEFAs also induced the growth of fibrils when their concentrations exceeded the binding capacity of albumin, indicating that the unbound NEFAs rather than albumin-bound NEFAs induce the fibril growth reaction in vitro. These results suggest the involvement of NEFAs in the development of Abeta2M amyloidosis, and in the pathogenesis of Abeta2M amyloidosis.


Subject(s)
Amyloid/metabolism , Fatty Acids, Nonesterified/pharmacology , beta 2-Microglobulin/physiology , Amyloid/drug effects , Amyloidosis/etiology , Humans , Hydrogen-Ion Concentration , Micelles , Oxidation-Reduction , Phosphatidic Acids/pharmacology , Protein Conformation , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Renal Dialysis/adverse effects , beta 2-Microglobulin/chemistry , beta 2-Microglobulin/metabolism
3.
Biochemistry ; 46(7): 1888-99, 2007 Feb 20.
Article in English | MEDLINE | ID: mdl-17253770

ABSTRACT

How various anti-amyloidogenic compounds inhibit the formation of Alzheimer's beta-amyloid fibrils (fAbeta) from amyloid beta-peptide (Abeta) and destabilize fAbeta remains poorly understood. Using spectrophotometry, spectrofluorometry, atomic force microscopy, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and surface plasmon resonance (SPR), we investigated the anti-amyloidogenic effects of five flavonoids on fAbeta in vitro. Oxidized flavonoids generally inhibited fAbeta(1-40) formation significantly more potently than fresh compounds. Characterization of the novel fluorescence of myricetin (Myr) emitted at 575 nm with an excitation maximum at 430 nm in the presence of fAbeta(1-40) revealed the specific binding of Myr to fAbeta(1-40). By SPR analysis, distinct association and dissociation reactions of Myr with fAbeta(1-40) were observed, in contrast to the very weak binding to the Abeta monomer. A significant decrease in the rate of fibril extension was observed when >0.5 microM Myr was injected into the SPR experimental system. These findings suggest that flavonoids, especially Myr, exert an anti-amyloidogenic effect in vitro by preferentially and reversibly binding to the amyloid fibril structure of fAbeta, rather than to Abeta monomers.


Subject(s)
Alzheimer Disease/metabolism , Amyloid/antagonists & inhibitors , Amyloid/chemistry , Flavonoids/chemistry , Amyloid beta-Peptides/antagonists & inhibitors , Amyloid beta-Peptides/chemistry , Electrophoresis, Polyacrylamide Gel , Microscopy, Atomic Force , Peptide Fragments/antagonists & inhibitors , Peptide Fragments/chemistry , Protein Binding , Spectrometry, Fluorescence , Spectrophotometry/methods , Surface Plasmon Resonance
SELECTION OF CITATIONS
SEARCH DETAIL
...